Home › Targets › MRGPRX2
MRGPRX2 (4 companies · 7 programs)
Companies with an active program directed at MRGPRX2.
- AB102 — Atopic Dermatitis Preclinical
- AB102 — Chronic Spontaneous Urticaria Preclinical
- EVO756 — Chronic Inducible Urticaria Phase 2
- EVO756 — Migraine Phase 2
- SEP-631 — Chronic Inducible Urticaria
- SEP-631 — Chronic Spontaneous Urticaria Phase 1
- EPS-5336 — Migraine Preclinical